Why Is BRIGHTSPRING HEALTH (BTSG) Stock Up Today?

BrightSpring Health Services (BTSG) shares surged 13.14% to $68.13 following the release of third-quarter financial results. The primary driver was a significant beat on both earnings and revenue, coupled with a substantial upward revision to full-year 2026 guidance.

What Happened

The company reported third-quarter continuing operations earnings per share of $0.46, slightly below the consensus estimate of $0.47. However, non-GAAP EPS of $0.54 exceeded estimates by $0.07. Revenue for the quarter reached $4.21 billion, surpassing the $3.875 billion estimate by $340 million. Management raised full-year 2026 revenue guidance from a previous range of $15.1 billion to $15.425 billion to a new range of $15.9 billion to $16.125 billion. This increase compares favorably against the prior consensus estimate of $15.346 billion. The company filed a Form 8-K with the SEC on October 30, 2026, to disclose these results and financial statements.

What The Data Shows

The stock opened at $62.61, representing a 4.0% gap from the prior close of $60.22. Intraday trading reached a high of $71.12 at 9:35 AM ET and a low of $62.48 at 7:00 AM ET. Volume stood at 0.7 million shares, which is 0.2 times the three-month daily average. The company’s market capitalization is $12.4 billion with a P/E ratio of 54.2. Trailing twelve-month revenue growth stands at 26.4%, while the net margin is 2.5%. The stock printed five fresh 52-week highs on October 30, 2026. Over the last 8 sessions, the stock had moved -0.4%. Recent insider activity includes one sale totaling $874,000 by Scott A. Greenwell, President of PharMerica, on September 14, 2026. Congressional disclosures show two buys and two sells in the last 90 days, with the most recent filing on September 22, 2026.

What To Watch

Analysts will monitor how the raised guidance impacts future valuation metrics, particularly given the high beta of 1.88 and the stock’s position near its 52-week high of $73.75.